Sterling Global Strategies’s Merck MRK Stock Holding History

Sterling Global Strategies’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-79	Closed	-$5.73K	–	125
2018 Q4	$5.73K	Buy	+79	New	+$5.58K	0.03%	173

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Sterling Global Strategies's MRK Position: Q1 2019 in Review

Sterling Global Strategies sold out of Merck (MRK) in Q1 2019, closing a stake of 79 shares — an estimated $5.73K sold.

Sterling Global Strategies first reported a position in MRK in Q4 2018 and held it in 1 quarter. The position peaked at $5.73K in Q4 2018. 2,292 funds tracked by Wall St. Rank hold MRK as of Q1 2019.

Sterling Global Strategies reported no remaining Merck position as of Q1 2019 after selling out during the quarter.
Sterling Global Strategies sold 79 Merck shares in Q1 2019, an estimated $5.73K.
Sterling Global Strategies first reported a position in Merck in Q4 2018 and held it in 1 quarter.
Sterling Global Strategies's Merck position peaked at $5.73K in Q4 2018.
2,292 funds tracked by Wall St. Rank held Merck as of Q1 2019.

Based on Sterling Global Strategies's 13F filing for Q1 2019, filed 15 May 2019.